REQUEST A DEMO
Total
USD $0.00
Search more companies

Am Medical S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Am Medical S.A.S. Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Am Medical S.A.S. is an enterprise based in Colombia. Its main office is in Valledupar. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on September 12, 2006. The company’s latest financial report indicates a net sales revenue increase of 46.95% in 2024. Its’ total assets recorded a growth of 57.45%. The net profit margin of Am Medical S.A.S. increased by 1.66% in 2024.

Headquarters
Calle 13Bbis 17 54
Valledupar; Cesar;

Contact Details: Purchase the Am Medical S.A.S. report to view the information.

Basic Information
Registered Capital:
Purchase the Am Medical S.A.S. report to view the information.
Financial Auditors:
Purchase the Am Medical S.A.S. report to view the information.
Incorporation Date:
September 12, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Company Performance
Financial values in the chart are available after Am Medical S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
46.95%
Total operating revenue
51.52%
Operating profit (EBIT)
94.05%
EBITDA
94.05%
Net Profit (Loss) for the Period
61.92%
Total Assets
57.45%
Total Equity
41.07%
Operating Profit Margin (ROS)
6.89%
Net Profit Margin
1.66%
Return on Equity (ROE)
4.69%
Debt/Equity
-0.19%
Quick Ratio
0.34%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?